Cigna sells its life, accident and allied businesses to Chubb for US $ 5.75 billion
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
This opens up a huge market for the company’s Magnezis implants in India
The company plans to expand its portfolio in regulated markets aggressively
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
The transaction is anticipated to close in the first quarter of 2022
A total of 8308 stores are open across India and medicines are priced at affordable rates
Subscribe To Our Newsletter & Stay Updated